Angion Biomedica Corp announced that it will receive $5,438,891 in funding on January 11, 2017. The company will issue common shares and option, warrant or other right to acquire another security in the transaction. The minimum investment accepted from any outside investor is $50,063. The company paid a sales commission of $363,222 and issued 446 series B warrants and reimbursement of $25,000 in expenses to T.R. Winston & Company, LLC. The company will issue securities pursuant to exemption provided under Regulation D.